TORONTO, July 09, 2018 (GLOBE NEWSWIRE) — Scythian Biosciences Corp. (the “Company” or “Scythian”) (TSXV:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Colombian-based Colcanna SAS (“Colcanna”), the pending acquisition by Scythian, has received additional licences by the Ministry of Health for the extraction, production and research for the local market and export to international markets of cannabis derivatives.
Read the full press release: http://globenewswire.com/news-release/2018/07/09/1534622/0/en/Scythian-Biosciences-Corp-Announces-Colcanna-SAS-as-one-of-the-Industry-s-First-to-Receive-Key-Cannabis-Licences-for-the-Cultivation-Extraction-Production-and-Research-of-Medical-C.html
Get Real-Time Updates from MJobserver.com